Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the number of nightly breath-stopping events by 46.8%, hitting the test's ...

LunAIRo, Apnimed's second Phase 3 trial of AD109, met its primary endpoint, demonstrating a reduction in the Apnea-Hypopnea Index (AHI) f ...

This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the signs are more subtle, research suggests as many as 90% of women who have ...

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative ...

The possibility of a dementia diagnosis may have a new origin, according to a recent study from UC Irvine. Medical research ...

A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...

Most associate sleep apnea with snoring, but it’s the sound of silence doctors say patients should be concerned with.

Sleep apnea can have untold consequences even in your waking hours. The good news? The condition is treatable.

A new study found active-duty service members with sleep apnea face a greater risk of PTSD or a traumatic brain injury, ...

Content by Advanced Dental Sleep Treatment Center. Thankfully, there is a treatment that’s effective, sustainable and ...

If left untreated, obstructive sleep apnea raises the risk of hypertension, heart disease, type 2 diabetes, depression and even an early death, according to the American Academy of Sleep Medicine.

The sleep apnea detection feature that Apple's most recent Apple Watch models offer has expanded to several more countries in ...